Table of Contents Table of Contents
Previous Page  979 / 1835 Next Page
Information
Show Menu
Previous Page 979 / 1835 Next Page
Page Background

How radical should RT be?

Prognostic factors:

Patient:

age – comorbidities

Initial disease:

stage – B symp – EN sites

Previous Rx:

Rituximab - RT - ASCT

Relapse:

Primary refractory v Relapse from remission

Disease-free interval

Extent of relapse

Aim of salvage